These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

510 related items for PubMed ID: 17711927

  • 1. Thyroid hormone replacement for central hypothyroidism: a randomized controlled trial comparing two doses of thyroxine (T4) with a combination of T4 and triiodothyronine.
    Slawik M, Klawitter B, Meiser E, Schories M, Zwermann O, Borm K, Peper M, Lubrich B, Hug MJ, Nauck M, Olschewski M, Beuschlein F, Reincke M.
    J Clin Endocrinol Metab; 2007 Nov; 92(11):4115-22. PubMed ID: 17711927
    [Abstract] [Full Text] [Related]

  • 2. Replacement therapy with levothyroxine plus triiodothyronine (bioavailable molar ratio 14 : 1) is not superior to thyroxine alone to improve well-being and cognitive performance in hypothyroidism.
    Siegmund W, Spieker K, Weike AI, Giessmann T, Modess C, Dabers T, Kirsch G, Sänger E, Engel G, Hamm AO, Nauck M, Meng W.
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):750-7. PubMed ID: 15163340
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of the adequacy of levothyroxine replacement therapy in patients with central hypothyroidism.
    Ferretti E, Persani L, Jaffrain-Rea ML, Giambona S, Tamburrano G, Beck-Peccoz P.
    J Clin Endocrinol Metab; 1999 Mar; 84(3):924-9. PubMed ID: 10084572
    [Abstract] [Full Text] [Related]

  • 4. Diagnosis and treatment of hypothyroidism in TSH deficiency compared to primary thyroid disease: pituitary patients are at risk of under-replacement with levothyroxine.
    Koulouri O, Auldin MA, Agarwal R, Kieffer V, Robertson C, Falconer Smith J, Levy MJ, Howlett TA.
    Clin Endocrinol (Oxf); 2011 Jun; 74(6):744-9. PubMed ID: 21521256
    [Abstract] [Full Text] [Related]

  • 5. Small changes in thyroxine dosage do not produce measurable changes in hypothyroid symptoms, well-being, or quality of life: results of a double-blind, randomized clinical trial.
    Walsh JP, Ward LC, Burke V, Bhagat CI, Shiels L, Henley D, Gillett MJ, Gilbert R, Tanner M, Stuckey BG.
    J Clin Endocrinol Metab; 2006 Jul; 91(7):2624-30. PubMed ID: 16670161
    [Abstract] [Full Text] [Related]

  • 6. Seasonal variation of serum thyrotropin concentration and thyrotropin response to thyrotropin-releasing hormone in patients with primary hypothyroidism on constant replacement dosage of thyroxine.
    Konno N, Morikawa K.
    J Clin Endocrinol Metab; 1982 Jun; 54(6):1118-24. PubMed ID: 6804476
    [Abstract] [Full Text] [Related]

  • 7. Thyroid hormone replacement therapy in primary hypothyroidism: a randomized trial comparing L-thyroxine plus liothyronine with L-thyroxine alone.
    Escobar-Morreale HF, Botella-Carretero JI, Gómez-Bueno M, Galán JM, Barrios V, Sancho J.
    Ann Intern Med; 2005 Mar 15; 142(6):412-24. PubMed ID: 15767619
    [Abstract] [Full Text] [Related]

  • 8. A randomized controlled trial of the effect of thyroxine replacement on cognitive function in community-living elderly subjects with subclinical hypothyroidism: the Birmingham Elderly Thyroid study.
    Parle J, Roberts L, Wilson S, Pattison H, Roalfe A, Haque MS, Heath C, Sheppard M, Franklyn J, Hobbs FD.
    J Clin Endocrinol Metab; 2010 Aug 15; 95(8):3623-32. PubMed ID: 20501682
    [Abstract] [Full Text] [Related]

  • 9. The different requirement of L-T4 therapy in congenital athyreosis compared with adult-acquired hypothyroidism suggests a persisting thyroid hormone resistance at the hypothalamic-pituitary level.
    Bagattini B, Cosmo CD, Montanelli L, Piaggi P, Ciampi M, Agretti P, Marco GD, Vitti P, Tonacchera M.
    Eur J Endocrinol; 2014 Nov 15; 171(5):615-21. PubMed ID: 25305309
    [Abstract] [Full Text] [Related]

  • 10. The beneficial effect of L-thyroxine on cardiovascular risk factors, endothelial function, and quality of life in subclinical hypothyroidism: randomized, crossover trial.
    Razvi S, Ingoe L, Keeka G, Oates C, McMillan C, Weaver JU.
    J Clin Endocrinol Metab; 2007 May 15; 92(5):1715-23. PubMed ID: 17299073
    [Abstract] [Full Text] [Related]

  • 11. Does a combination regimen of thyroxine (T4) and 3,5,3'-triiodothyronine improve depressive symptoms better than T4 alone in patients with hypothyroidism? Results of a double-blind, randomized, controlled trial.
    Sawka AM, Gerstein HC, Marriott MJ, MacQueen GM, Joffe RT.
    J Clin Endocrinol Metab; 2003 Oct 15; 88(10):4551-5. PubMed ID: 14557420
    [Abstract] [Full Text] [Related]

  • 12. Thyroxine replacement therapy and circulating lipid concentrations.
    Franklyn JA, Daykin J, Betteridge J, Hughes EA, Holder R, Jones SR, Sheppard MC.
    Clin Endocrinol (Oxf); 1993 May 15; 38(5):453-9. PubMed ID: 8330440
    [Abstract] [Full Text] [Related]

  • 13. Partial substitution of thyroxine (T4) with tri-iodothyronine in patients on T4 replacement therapy: results of a large community-based randomized controlled trial.
    Saravanan P, Simmons DJ, Greenwood R, Peters TJ, Dayan CM.
    J Clin Endocrinol Metab; 2005 Feb 15; 90(2):805-12. PubMed ID: 15585551
    [Abstract] [Full Text] [Related]

  • 14. Combined thyroxine/liothyronine treatment does not improve well-being, quality of life, or cognitive function compared to thyroxine alone: a randomized controlled trial in patients with primary hypothyroidism.
    Walsh JP, Shiels L, Lim EM, Bhagat CI, Ward LC, Stuckey BG, Dhaliwal SS, Chew GT, Bhagat MC, Cussons AJ.
    J Clin Endocrinol Metab; 2003 Oct 15; 88(10):4543-50. PubMed ID: 14557419
    [Abstract] [Full Text] [Related]

  • 15. Treatment of hypothyroidism with once weekly thyroxine.
    Grebe SK, Cooke RR, Ford HC, Fagerström JN, Cordwell DP, Lever NA, Purdie GL, Feek CM.
    J Clin Endocrinol Metab; 1997 Mar 15; 82(3):870-5. PubMed ID: 9062499
    [Abstract] [Full Text] [Related]

  • 16. Central hypothyroidism and its replacement have a significant influence on cardiovascular risk factors in adult hypopituitary patients.
    Klose M, Marina D, Hartoft-Nielsen ML, Klefter O, Gavan V, Hilsted L, Rasmussen AK, Feldt-Rasmussen U.
    J Clin Endocrinol Metab; 2013 Sep 15; 98(9):3802-10. PubMed ID: 23796569
    [Abstract] [Full Text] [Related]

  • 17. Twenty-four hour hormone profiles of TSH, Free T3 and free T4 in hypothyroid patients on combined T3/T4 therapy.
    Saravanan P, Siddique H, Simmons DJ, Greenwood R, Dayan CM.
    Exp Clin Endocrinol Diabetes; 2007 Apr 15; 115(4):261-7. PubMed ID: 17479444
    [Abstract] [Full Text] [Related]

  • 18. Combined levothyroxine plus liothyronine compared with levothyroxine alone in primary hypothyroidism: a randomized controlled trial.
    Clyde PW, Harari AE, Getka EJ, Shakir KM.
    JAMA; 2003 Dec 10; 290(22):2952-8. PubMed ID: 14665656
    [Abstract] [Full Text] [Related]

  • 19. Metabolic effects of liothyronine therapy in hypothyroidism: a randomized, double-blind, crossover trial of liothyronine versus levothyroxine.
    Celi FS, Zemskova M, Linderman JD, Smith S, Drinkard B, Sachdev V, Skarulis MC, Kozlosky M, Csako G, Costello R, Pucino F.
    J Clin Endocrinol Metab; 2011 Nov 10; 96(11):3466-74. PubMed ID: 21865366
    [Abstract] [Full Text] [Related]

  • 20. Effects of thyroxine as compared with thyroxine plus triiodothyronine in patients with hypothyroidism.
    Bunevicius R, Kazanavicius G, Zalinkevicius R, Prange AJ.
    N Engl J Med; 1999 Feb 11; 340(6):424-9. PubMed ID: 9971866
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.